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Background: The development of cardiogenic shock (CS) post ST-elevation Myocardial Infarction (STEMI) is associated with high rates of mortality. 
Early revascularization has been shown to improve mortality in patients <75 years old but showed no benefit in those patients ≥75 years old. It is 
unclear in a real world clinical practice what outcomes are associated with patients who develop CS due to a STEMI.
Methods: The University of Ottawa Heart Institute has developed a citywide protocol in which all patients who presented with STEMI were treated 
with primary PCI (PPCI) at one cardiac center. Consecutive patients who developed CS post STEMI and who were treated with PPCI were identified. 
We sought to assess the differences in clinical outcomes for patients <75 years old compared with those ≥75 years old. Patients were defined as 
having CS if they had a systolic blood pressure < 80mmHG which did not respond to fluid expansion, and required the use of intravenous inotropic 
support or the use of intraaortic balloon counterpulsation.
Results: Of patients presenting between 08/01/2004 and 12/31/2008 for PPCI, 112 developed CS while in hospital. Sixty-six (59%) patients were 
<75 years of age and 46 were ≥75 years of age. All patients had PCI attempted. Post-procedure TIMI grade 3 was reported in 77% in those <75 and 
in 73% in those ≥75 years old (p=0.82). Nine patients <75 years old underwent subsequent CABG compared with 1 patient in those ≥75 years old 
(p =0.05). The door to balloon time was 110.5 and 122 minutes in the younger and older age groups, respectively (p=0.21). The in-hospital mortality 
rate for all patients who developed CS was 40%. The in-hospital mortality rate was significantly higher in those ≥75 compared to <75 years of age 
(59% and 27%, respectively; p=0.002). At 6 months, mortality was 65% in patients ≥75 years old vs. 33% <75 years old. (p=0.001).
Conclusion: Of patients who develop CS after a STEMI in the setting of primary PCI, those ≥75 years of age have a higher mortality rate than 
those <75 years of age. Mortality in both groups was lower than previously seen in a randomized control trial. This suggests a dedicated Primary PCI 
protocol may improve mortality in patients who develop CS post STEMI.
